Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
Synthetic peptide contain a sequence corresponding to a region within amino acids 135 and 202 of Human IGFBP3
Localization:
Secreted
Species Reactivity:
Tested in human. Not yet tested in any other species.
Applications:
Uses:
Western blot. The usefulness of this product in other applications has not been determined.
Dilutions:
Western Blot 1:500-1:3000
Unit Size:
0.1 ml
Concentration:
0.3 mg/ml
Packaging:
Storage:
Store at -20 °C. Avoid freeze-thaw cycles.
Buffer:
0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7.0).
Preservative:
0.01% Thimerosal
Limitations:
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein forms a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq]